C. Fathman

发表

Treatment of Autoimmune Disease by Adoptive Cellular Gene Therapy

G. Nolan, C. Contag, I. Tarner, 2003, Annals of the New York Academy of Sciences.

Vitamin D Deficiency in a Multiethnic Healthy Control Cohort and Altered Immune Response in Vitamin D Deficient European-American Healthy Controls

Lauren L. Ritterhouse, H. Maecker, T. Scriba, 2014, PloS one.

Large-Scale and Comprehensive Immune Profiling and Functional Analysis of Normal Human Aging

Ash A. Alizadeh, Aaron M. Newman, C. Garrison Fathman, 2015, PloS one.

New technologies for autoimmune disease monitoring

G. Nolan, H. Maecker, C. Fathman, 2010, Current opinion in endocrinology, diabetes, and obesity.

New tools for classification and monitoring of autoimmune diseases

S. Shen-Orr, H. Maecker, M. Hale, 2012, Nature Reviews Rheumatology.

Autoimmune Disease: Modulation of T Cell Encoding a Self-Peptide Prevents Suppressive Immunization with DNA

H. Garren, D. Mitchell, L. Steinman, 1999 .

New tools for classification and monitoring of autoimmune diseases

S. Shen-Orr, W. Robinson, H. Maecker, 2012, Nature Reviews Rheumatology.

Identification of a common immune regulatory pathway induced by small heat shock proteins, amyloid fibrils, and nicotine

J. Rothbard, L. Steinman, L. Soares, 2018, Proceedings of the National Academy of Sciences.

Autoantibody‐Positive Healthy Individuals Display Unique Immune Profiles That May Regulate Autoimmunity

Lauren L. Ritterhouse, H. Maecker, J. Guthridge, 2016, Arthritis & rheumatology.

Mass cytometry as a platform for the discovery of cellular biomarkers to guide effective rheumatic disease therapy

G. Nolan, M. Genovese, H. Maecker, 2015, Arthritis Research & Therapy.

Targeted gene therapy of autoimmune diseases: advances and prospects

U. Müller-Ladner, I. Tarner, C. Fathman, 2005, Expert review of clinical immunology.

Protein microarrays for multiplex analysis of signal transduction pathways

Paul J Utz, Steven M Chan, Steven M. Chan, 2004, Nature Medicine.

Concise Review: Cell‐Based Therapies and Other Non‐Traditional Approaches for Type 1 Diabetes

M. Battaglia, M. Roncarolo, C. Fathman, 2016, Stem cells.

Autoimmune diseases: genes, bugs and failed regulation

C. Fathman, J. Ermann, C. Fathman, 2001, Nature Immunology.

An array of possibilities for the study of autoimmunity

Luis Soares, Steven M. Chan, P. Utz, 2005, Nature.

Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen

L. Steinman, C. Fathman, C. Piercy, 1993, Nature.

Differential mTOR and ERK pathway utilization by effector CD4 T cells suggests combinatorial drug therapy of arthritis.

W. Robinson, M. T. Wong, P. Utz, 2012, Clinical immunology.

Cd4+Cd25+ regulatory T cells and their therapeutic potential.

C. Fathman, D. Randolph, C. Fathman, 2006, Annual review of medicine.

The potential for gene therapy in the treatment of autoimmune disease.

I. Tarner, C. Fathman, C. Fathman, 2002, Clinical immunology.

Gene Expression Analysis of the Pre-Diabetic Pancreas to Identify Pathogenic Mechanisms and Biomarkers of Type 1 Diabetes

C. Fathman, Linda Yip, Rebecca A Fuhlbrigge, 2020, Frontiers in Endocrinology.

Molecular mechanisms of CD4+ T-cell anergy

C. Fathman, N. Lineberry, C. Fathman, 2007, Nature Reviews Immunology.

Therapeutic Effects of Systemic Administration of Chaperone αB-Crystallin Associated with Binding Proinflammatory Plasma Proteins*

Rong Chen, S. Brownell, J. Rothbard, 2012, Journal of Biological Chemistry.

Therapeutic Effects of Systemic Administration of Chaperone B-Crystallin Associated with Binding Proinflammatory Plasma Proteins *

Rong Chen, S. Brownell, W. Robinson, 2012 .

Type 1 diabetes in mice and men: gene expression profiling to investigate disease pathogenesis

C. Fathman, Linda Yip, C. Fathman, 2014, Immunologic Research.

Reduced DEAF1 function during type 1 diabetes inhibits translation in lymph node stromal cells by suppressing Eif4g3.

Cara T. Pager, P. Sarnow, C. Fathman, 2013, Journal of molecular cell biology.

Amyloid fibrils activate B-1a lymphocytes to ameliorate inflammatory brain disease

J. Rothbard, L. Steinman, L. Herzenberg, 2015, Proceedings of the National Academy of Sciences.

Naive CD4 T Cell Proliferation Is Controlled by Mammalian Target of Rapamycin Regulation of GRAIL Expression1

P. Utz, C. Fathman, Michael G. Kattah, 2009, The Journal of Immunology.

Redirecting cell-type specific cytokine responses with engineered interleukin-4 superkines

Michael N. Alonso, K. Garcia, M. Meier-Schellersheim, 2012, Nature chemical biology.

Expression-Based Genome-Wide Association Study Links Vitamin D–Binding Protein With Autoantigenicity in Type 1 Diabetes

A. Butte, Liping Yu, K. Kodama, 2016, Diabetes.

Retroviral gene therapy of collagen-induced arthritis by local delivery of IL-4.

C. Contag, I. Tarner, C. Fathman, 2002, Clinical Immunology.

Deaf1 isoforms control the expression of genes encoding peripheral tissue antigens in the pancreatic lymph nodes during type 1 diabetes

S. Turley, M. Atkinson, P. Albert, 2009, Nature Immunology.

A model for harmonizing flow cytometry in clinical trials

F. Villanova, P. Di Meglio, M. Peakman, 2010, Nature Immunology.

Tissue- and age-specific changes in gene expression during disease induction and progression in NOD mice.

Atul J Butte, A. Butte, K. Kodama, 2008, Clinical immunology.